Bridging the Gap - FlowCam Nano Makes Connections in Human Health Research

Bridging the Gap - FlowCam Nano Makes Connections in Human Health Research

Flow Imaging Microscopy (FIM) is finding its pulse in human health applications through our collaboration with the MaineHealth Institute for Research (MHIR). We teamed up with scientists from the Myocardial Biology and Heart Failure (MBHF) research lab in the Center for Molecular Medicine (CMM) to demonstrate the value of FlowCam Nano in translational research. Our MBHF partners are especially interested in the changes that occur in the particle composition of biological fluids in response to cardiac stress, and they are asking questions that are aimed at moving basic science discoveries into clinical practice. With FlowCam Nano, we hope to help them find answers that can bridge that bench-to-bedside gap and benefit human health.

Virtually all cells release extracellular particles of various shapes and sizes into biological fluids (including blood, saliva, sputum, tears, and cerebrospinal fluid) due to normal cellular processes.1 Extracellular vesicles (EVs) are a class of extracellular particles that have a spherical structure composed of a lipid bilayer. EVs include exosomes (size range of 30-100 nm), microvesicles (MVs), (size range of 100-700 nm), and apoptotic bodies (sizes of up to 5 µm) – the latter of which may contain organelles and nuclear components.2 After an event like cardiac arrest, changes in EVs sizes, morphologies, concentrations, and size distributions can reveal the severity of tissue damage in the heart and/or brain and thus could be used for diagnosis, monitoring, and even the development of new therapies for various cardiovascular conditions.3,4 

Characterizing particles in the 300 nm to 2 µm range in human plasma is no small task, but the dynamic imaging capabilities of FlowCam Nano make it possible. Using a 40X objective, the instrument captures high-resolution images of submicron particles, while VisualSpreadsheet software creates a catalog of morphological features that can be culled for meaningful trends in particle properties. So far, FlowCam Nano has given our MBHF collaborators a close-up view of submicron particles in biological fluid samples. We look forward to furthering our detailed analysis already in progress and adding value to the wealth of metadata and molecular information they have accumulated over the years.

The four collages below show FlowCam Nano images of extracellular vesicles obtained from four different biological fluid samples. 

FlowCam Nano collages of extracellular vesicles

Central to MHIR’s research success is the collaborative network it fosters among Maine Medical Center physicians and other investigators in the region. We are excited about our collaboration with MHIR and the opportunity to explore the biological fluid imaging capabilities of FlowCam Nano.

When asked what the big picture of their research mission is, our MBHF collaborators, Sergey Ryzhov, MD, Ph.D., and Joanne Taylor deKay, MS, said quite simply: “To help people rejuvenate their aging hearts and improve their overall cardiovascular health." Perhaps together, we can.

Learn more about how FlowCam Nano can provide early detection of aggregation in formulations. 


Download White Paper

 

References
  1. Neri T, Celi A, Tinè M, Bernardinello N, Cosio MG, Saetta M, Nieri D, Bazzan E. The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPD. International Journal of Molecular Sciences. 2022; 23(9):5136. https://doi.org/10.3390/ijms23095136

  2. Pulliero A, Pergoli L, LA Maestra S, Micale RT, Camoirano A, Bollati V, Izzotti A, DE Flora S. Extracellular vesicles in biological fluids. A biomarker of exposure to cigarette smoke and treatment with chemopreventive drugs. J Prev Med Hyg. 2019 Dec 20;60(4):E327-E336. doi: 10.15167/2421-4248/jpmh2019.60.4.1284. PMID: 31967089; PMCID: PMC6953455.

  3. deKay JT, May TL, Riker RR, Rud J, Gagnon DJ, Sawyer DB, Seder DB, Ryzhov S. The number of circulating CD26 expressing cells is decreased in critical COVID-19 illness. Cytometry A. 2023 Feb;103(2):153-161. doi: 10.1002/cyto.a.24547. Epub 2022 Mar 16. PMID: 35246910; PMCID: PMC9087143.

  4. Fu, S., Zhang, Y., Li, Y. et al. Extracellular vesicles in cardiovascular diseases. Cell Death Discov. 6, 68 (2020). https://doi.org/10.1038/s41420-020-00305-y

Post Topics

Related Posts

Preventing Embolism from Active Implantable Medical Devices
The risk of embolism, caused by particulate matter shed from medical device delivery systems, is a growing concern in the medical field. Ensuring …
Read Post
Rendering of organoids
How to Image Organoids with FlowCam - Advancing disease modeling & therapeutic drug screening
Animal testing for every new drug development protocol has been a requirement since the original 1938 passing of the US Federal Food, Drug, and …
Read Post
Need Supplies?

Find supplies and spare parts for your FlowCam instrument or ask for a quote. 

Order Now

Need Help?

Get technical support and application help. Request training or preventative maintenance.


Submit a Support Ticket

Need Information?

Check out our knowledge base including white papers, application notes, technical notes, and videos.

View Resources